HOME >> BIOLOGY >> NEWS
Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies

(Philadelphia, PA) Researchers at the Leonard and Madlyn Abramson Family Cancer Research Institute at the University of Pennsylvania have found a second way by which chemotherapeutic agents can kill cancer cells. The finding which will appear online and ahead of print in the June 1st edition of the journal Genes & Development represents an important advance in understanding how and why some cancer cells die and others do not in response to existing chemotherapy. The results suggest the possibility that targeted therapies can be developed which will force cancer cells to die before they can grow into tumors.

"This finding shows, for the first time, that cancer cells are unusually sensitive to dying by necrosis, when their ability to metabolize glucose is blocked," said Craig Thompson, MD, Principal Investigator of the study and Scientific Director of the Abramson Family Cancer Research Institute (AFCRI). "Up until now, research has focused on finding ways to program cancer cells to die through apoptosis a very regulated, orderly form of cell death that does not trigger an immune response. Now, we know that cancer cells can be forced to die, suddenly, through necrosis. If we can harness this method, which does trigger an immune response, then, the door will be opened to a whole new and less toxic way to treat cancer."

Despite long-term use, the action of chemotherapeutic agents to kill and stop the growth of cancer cells is not well understood. The agents have proven to be effective treatments even for tumors lacking the genes considered essential for apoptosis, but the precise cellular mechanism for this has remained unexplained up until now.

To study this issue, the researchers created mouse cells that were unable to die by apoptosis. The cells were engineered to be deficient in either the tumor suppressor gene p53, the most commonly mutated gene in human cancer, or two key proteins essential for the execution of apoptotic cell death,
'"/>

Contact: David March
david.march@uphs.upenn.edu
215-615-3353
University of Pennsylvania School of Medicine
13-May-2004


Page: 1 2 3

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/3/2020)... LAGUNA HILLS, Calif. (PRWEB) , ... March 03, 2020 , ... ... 300 spinal levels with the dualX Expanding Interbody Fusion System. , The ... in Fresno, CA. After the case Dr. Najafi noted, “dualX has completely changed ...
(Date:3/2/2020)... ... ... Nominations are now being accepted for the 2020 Women in Biometrics ... and SecureIDNews and co-presented with sponsors IDEMIA , Biometric Update ... year’s Women in Biometrics Awards will be honored at the 2020 SIA GovSummit, held ...
(Date:2/28/2020)... Fla. (PRWEB) , ... February 27, 2020 , ... ... to broadcast 2Q/2020, will explore innovative treatment solutions for maladies, such as Inflammatory ... more info. , This segment will focus on a novel platform developed ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... ... March 10, 2020 , ... Lifecycle Biotechnologies announced today ... Cleburne, Texas to be used as a biopharmaceutical and biotechnology production and development campus. ... offices as well as its production and development hub. The company expects to relocate ...
(Date:3/2/2020)... ... ... McBee, Moore and Vanik IP, LLC (MMV IP) has been ranked 12th ... , According to statistics compiled by Harrity Anaytics, MMV IP was listed as the ... during 2019. Technology center 1600 at the US Patent Office (“USPTO”) specializes in the ...
(Date:2/21/2020)... PURCHASE, N.Y. (PRWEB) , ... February 20, 2020 ... ... solution for ensuring supply chain transparency and reassuring consumers that what’s listed on ... patented and trademarked ingredients, Nutrition21 has introduced this solution with the adoption of ...
(Date:2/19/2020)... , ... February 19, 2020 , ... ... solutions for the life sciences industry, today announced the opening of a new ... Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office in ...
Breaking Biology Technology:
Cached News: